Report Feature
The future of the global epigenetics market looks promising with opportunities in the oncology, metabolic diseases, developmental biology, immunology, and cardiovascular diseases. The global epigenetics market is expected to grow with a CAGR of 13%-15% from 2020 to 2025. The major drivers for this market are increasing prevalence of cancer, increasing research and development activities, and increasing development in pharmaceutical and biotechnology sector.
A total of XX figures / charts and XX tables are provided in more than 150 pages report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global epigenetics market report, please download the report brochure.
In this market, kits is the fastest growing product type of epigenetics, whereas oncology is the largest application. Growth in various segments of the epigenetics market are given below:
The study includes trends and forecast for the global epigenetics market by product, technology, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
- Kits
- Reagents
- Enzymes
- Instruments and Consumables
- Bioinformatic Tools
By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:
- DNA Methylation
- Histone Modification
- Other Technologies
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Oncology
- Metabolic Diseases
- Developmental Biology
- Immunology
- Cardiovascular Diseases
- Other Applications
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organizations Oncology
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
- North America
- United States
- Canada
- Mexico
- Europe
- United Kingdom
- German
- France
- Asia Pacific
- China
- India
- Japan
- The Rest of the World
- Brazil
Some of the epigenetics companies profiled in this report include Abcam, Illumina, QIAGEN, Merck & Co., New England Biolabs, Epizyme, Thermo Fisher Scientific, Active Motif. Diagenode, Zymo Research, and Domainex.
Lucintel forecasts that the kits will remain the highest-growing segment over the forecast period due to increasing prevalence of chronic diseases and increasing government fundings for life science research.
Within this market, oncology will remain the largest segment by application over the forecast period due to rising death cases due to cancer and new product development for treatment of diseases related to oncology.
North America will remain the largest region over the forecast period due to increasing government fundings for research related to epigenetics and technological development in the region.
|
Features of the Global Epigenetics Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global epigenetics market by product (kits, reagents, enzymes, instruments and consumables, and bioinformatic tools), technology (DNA methylation, histone modification, and other technologies), application (oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases, and other applications), end user (academic and research institutes, pharmaceutical and biotechnology companies, and contract research organizations oncology), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global epigenetics market? Q.5 What are the business risks and threats to the global epigenetics market? Q.6 What are emerging trends in this epigenetics market and the reasons behind them? Q.7 What are some changing demands of customers in this epigenetics market? Q.8 What are the new developments in this epigenetics market? Which companies are leading these developments? Q.9 Who are the major players in this epigenetics market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this epigenetics market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global epigenetics market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Product (Kits, Reagents, Enzymes, Instruments and Consumables, and Bioinformatic Tools), Technology (DNA Methylation, Histone Modification, and Other Technologies), Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications), and End User (Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations Oncology) |
|
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
7.2 Emerging Trends in the Global Epigenetics Market
4.1 Global Epigenetics Market by Region
4.2.1 Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.2.2 Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.2.3 Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.2.4 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.2.5 The United States Epigenetics Market
4.2.6 The Canadian Epigenetics Market
4.2.7 The Mexican Epigenetics Market
4.3.1 Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.3.2 Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.3.3 Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.3.4 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.3.5 The Epigenetics Market of United Kingdom
4.3.6 The German Epigenetics Market
4.3.7 The French Epigenetics Market
4.4.1 Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.4.2 Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.4.3 Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.4.4 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.4.5 The Chinese Epigenetics Market
4.4.6 The Indian Epigenetics Market
4.4.7 The Japanese Epigenetics Market
4.5.1 Market by Product: Kits, Reagents, Enzymes, Instruments and Consumables
4.5.2 Market by Technology: DNA Methylation, Histone Modification, and Other Technologies
4.5.3 Market by Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, and Other Applications
4.5.4 Market by End User: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Contract Research Organizations
4.5.5 Brazilian Epigenetics Market
7.1.1 Growth Opportunities for the Global Epigenetics Market by Product
7.1.2 Growth Opportunities for the Global Epigenetics Market by Technology
7.1.3 Growth Opportunities for the Global Epigenetics Market by Application
7.1.3 Growth Opportunities for the Global Epigenetics Market by End User
7.1.4 Growth Opportunities for the Global Epigenetics Market by Region
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
